• DOI:10.1097/YIC.0b013e32833a4d71
Corpus ID: 11103740

Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study

@article{Schutters2010MirtazapineIG,
  title={Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study},
  author={S. Schutters and H. V. van Megen and J. F. van Veen and D. Denys and H. Westenberg},
  journal={International Clinical Psychopharmacology},
  year={2010},
  volume={25},
  pages={302-304}
}

S. Schutters, H. V. van Megen, +2 authors H. Westenberg

Published 2010

Psychology, Medicine

International Clinical Psychopharmacology

This study is aimed at investigating the efficacy and tolerability of mirtazapine in a generalized social anxiety disorder. Sixty patients with generalized social anxiety disorder were randomly allocated to receive mirtazapine (30–45 mg/day) (n=30) or placebo (n=30) for 12 weeks in a double-blind study design. Primary efficacy was assessed by the Liebowitz Social Anxiety Scale (LSAS) and response to treatment was defined as a reduction of 40% on the LSAS and an improvement on the Clinical… CONTINUE READING

View on Wolters Kluwer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed